計算
競合他社との比較
産業部門との比較：医薬品とバイオテクノロジー
業界との比較：健康管理

Abbott Laboratories、純利益率、長期トレンド、計算

	純利益率	=	100	×	純利益¹	÷	純売上高¹
2019/12/31	11.56%	=	100	×	3,687	÷	31,904
2018/12/31	7.74%	=	100	×	2,368	÷	30,578
2017/12/31	1.74%	=	100	×	477	÷	27,390
2016/12/31	6.71%	=	100	×	1,400	÷	20,853
2015/12/31	21.68%	=	100	×	4,423	÷	20,405
2014/12/31	11.28%	=	100	×	2,284	÷	20,247
2013/12/31	11.79%	=	100	×	2,576	÷	21,848
2012/12/31	14.95%	=	100	×	5,963	÷	39,874
2011/12/31	12.17%	=	100	×	4,728	÷	38,851
2010/12/31	13.15%	=	100	×	4,626	÷	35,167
2009/12/31	18.68%	=	100	×	5,746	÷	30,765
2008/12/31	16.53%	=	100	×	4,881	÷	29,528
2007/12/31	13.92%	=	100	×	3,606	÷	25,914
2006/12/31	7.64%	=	100	×	1,717	÷	22,476
2005/12/31	15.10%	=	100	×	3,372	÷	22,338

ソース： Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)

¹ 百万ドル

Abbott Laboratories、純利益率、長期トレンド、競合他社との比較

	Abbott Laboratories	AbbVie Inc.	Amgen Inc.	Bristol-Myers Squibb Co.	Eli Lilly & Co.	Gilead Sciences Inc.	Illumina Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Regeneron Pharmaceuticals Inc.	Vertex Pharmaceuticals Inc.	Zoetis Inc.
2019/12/31	11.56%	23.69%	35.32%	13.15%	37.27%	24.35%	28.28%	18.42%	21.01%	31.45%	26.91%	28.27%	23.96%
2018/12/31	7.74%	17.36%	37.25%	21.81%	13.16%	25.16%	24.78%	18.75%	14.71%	20.79%	36.42%	68.80%	24.52%
2017/12/31	1.74%	18.82%	9.08%	4.85%	-0.89%	18.03%	26.38%	1.70%	5.97%	40.55%	20.41%	10.59%	16.28%
2016/12/31	6.71%	23.22%	35.27%	22.94%	12.90%	45.07%	19.29%	23.01%	9.85%	13.66%	18.42%	-6.58%	16.80%
2015/12/31	21.68%	22.50%	33.13%	9.45%	12.07%	56.32%	20.79%	21.99%	11.25%	14.25%	15.50%	-53.89%	7.11%
2014/12/31	11.28%	8.89%	26.69%	12.62%	12.19%	49.44%	18.98%	21.96%	28.22%	18.42%	12.34%	-127.25%	12.18%
2013/12/31	11.79%	21.97%	27.93%	15.64%	20.27%	28.46%	8.82%	19.40%	10.00%	42.65%	20.16%	-36.72%	11.05%
2012/12/31	14.95%	28.70%	26.11%	11.12%	18.09%	27.57%	13.17%	16.14%	13.05%	24.70%	54.43%	-7.01%	10.06%
2011/12/31	12.17%	—	24.08%	17.46%	17.90%	34.60%	8.21%	14.87%	13.05%	14.84%	-49.74%	2.10%	—
2010/12/31	13.15%	—	31.56%	15.92%	21.97%	39.26%	13.83%	21.65%	1.87%	12.18%	-22.76%	-526.35%	—
2009/12/31	18.68%	—	32.09%	56.42%	19.82%	40.74%	10.85%	19.82%	47.04%	17.27%	-17.88%	-630.27%	—
2008/12/31	16.53%	—	28.57%	25.47%	-10.17%	39.55%	8.81%	20.31%	32.74%	16.78%	-34.69%	-262.02%	—
2007/12/31	13.92%	—	22.12%	11.19%	15.85%	43.27%	-75.89%	17.31%	13.54%	16.82%	-84.46%	-196.61%	—
2006/12/31	7.64%	—	21.29%	8.85%	16.97%	-45.98%	21.65%	20.73%	19.59%	39.98%	-161.30%	-95.63%	—
2005/12/31	15.10%	—	30.56%	15.62%	13.52%	44.99%	-28.40%	20.61%	21.04%	15.76%	-144.19%	-126.43%	—

ソース： Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)

Abbott Laboratories、純利益率、長期トレンド、産業部門との比較：医薬品とバイオテクノロジー

	Abbott Laboratories	医薬品とバイオテクノロジー
2019/12/31	11.56%	23.19%
2018/12/31	7.74%	19.80%
2017/12/31	1.74%	12.42%
2016/12/31	6.71%	20.64%
2015/12/31	21.68%	21.84%
2014/12/31	11.28%	21.52%
2013/12/31	11.79%	22.06%
2012/12/31	14.95%	18.62%
2011/12/31	12.17%	15.49%
2010/12/31	13.15%	15.20%
2009/12/31	18.68%	26.25%
2008/12/31	16.53%	18.77%
2007/12/31	13.92%	16.05%
2006/12/31	7.64%	21.43%
2005/12/31	15.10%	18.36%

ソース： Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)

Abbott Laboratories、純利益率、長期トレンド、業界との比較：健康管理

	Abbott Laboratories	健康管理
2019/12/31	11.56%	16.41%
2018/12/31	7.74%	14.00%
2017/12/31	1.74%	9.98%
2016/12/31	6.71%	14.08%
2015/12/31	21.68%	15.10%
2014/12/31	11.28%	15.64%
2013/12/31	11.79%	16.36%
2012/12/31	14.95%	14.08%
2011/12/31	12.17%	13.09%
2010/12/31	13.15%	12.57%
2009/12/31	18.68%	18.67%
2008/12/31	16.53%	13.77%
2007/12/31	13.92%	13.29%
2006/12/31	7.64%	15.47%
2005/12/31	15.10%	15.88%

ソース： Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)

Abbott Laboratories (NYSE:ABT)

純利益率2005年以降

計算

競合他社との比較

産業部門との比較： 医薬品とバイオテクノロジー

業界との比較： 健康管理

純利益率
2005年以降

産業部門との比較：医薬品とバイオテクノロジー

業界との比較：健康管理